Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Ketorolac is a potent nonsteroidal anti-inflammatory (NSAID) used for short-term relief of moderate to severe acute pain, often after surgery, injury, kidney stones, or migraine attacks, and it works without the sedation or dependence risk of opioids. Its use is capped at five days total across all forms (IV, IM, oral, nasal) because longer exposure sharply raises the risk of stomach bleeding, ulcers, kidney injury, and cardiovascular events. Certain people should avoid it entirely, including those with bleeding disorders, peptic ulcers, advanced kidney disease, aspirin sensitivity, or an upcoming major surgery. There are several important dosing limits, drug interactions, and warning signs to consider, so see below to understand more.
Because severe pain can have many different underlying causes, and because some of them need urgent care rather than a strong painkiller, it helps to clarify what is actually driving your symptoms before your next appointment. A free, instant, online symptom check can help you organize your symptoms, flag possible causes, and understand which next steps make sense for your situation.
Last reviewed for medical accuracy: 09/29/2026
Ketorolac (sometimes misspelled as keterolac) is a powerful nonsteroidal anti-inflammatory drug (NSAID) prescribed for short-term relief of moderate to severe acute pain. Unlike milder NSAIDs you might take for headaches or muscle aches, ketorolac is often reserved for situations where stronger pain control is needed—think postoperative pain or kidney stone discomfort.
• Inhibits cyclooxygenase (COX) enzymes
• Reduces prostaglandin production (chemicals that cause pain, fever, and swelling)
• Delivers effective pain relief without opioids
By targeting COX-1 and COX-2 enzymes, ketorolac decreases the chemical signals that trigger inflammation and pain. Because it doesn’t act on opioid receptors, it avoids the sedation, respiratory depression, or addiction risk of opioid painkillers.
Ketorolac is approved for the short-term management (up to five days) of acute moderate to severe pain when other treatments aren’t sufficient. Common uses include:
Ketorolac is available in three main forms: intramuscular (IM) injection, intravenous (IV) injection, and oral tablets. Typical adult dosing:
Elderly patients (over 65 years), those under 50 kg, or with reduced kidney function often receive lower doses (oral max 20 mg/day; IV/IM max 60 mg/day). Always follow your doctor’s instructions exactly.
Ketorolac’s effectiveness for pain comes with a higher risk profile when used beyond five days. Key reasons for the five-day limit:
Longer courses raise the chances of serious side effects. For ongoing pain, your doctor will likely switch you to a safer, longer-term NSAID or explore alternative therapies.
Most people tolerate a short course of ketorolac well, but watch for:
If you notice black or bloody stools, vomiting blood, sudden weight gain, or severe headache, seek medical attention immediately.
Before taking ketorolac, let your doctor know if you have:
Ketorolac is not recommended during the later stages of pregnancy, and breastfeeding mothers should discuss potential risks.
Ketorolac can interact with:
Always provide your healthcare team with a complete list of medications and supplements you’re taking.
While ketorolac offers fast relief, serious reactions—though rare—can occur. Contact a doctor or head to the emergency room if you experience:
If you’re unsure whether your symptom is serious, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Ketorolac provides powerful short-term pain relief, but it’s not risk-free. Always follow your prescriber’s advice, adhere to the five-day limit, and report any unusual symptoms right away. If you have life-threatening or serious concerns—such as severe bleeding, allergic reactions, or signs of kidney failure—speak to a doctor or seek emergency care immediately.
By understanding what ketorolac does and why its use must be limited, you can use it safely and effectively under medical supervision. Discuss any questions or worries with your healthcare provider before starting treatment.
(References)
* Sanders DY, Severance HW, Pollack CV Jr. Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department. South Med J. 1992 Aug;85(8):808-11. doi: 10.1097/00007611-199208000-00005. PMID: 1302470.
* Durante E, Dal Prà ML, Pampolini M. [I.V. ketorolac in the therapy of postoperative pain]. G Chir. 1990 Apr;11(4):243-6. PMID: 2223517.
* Lebedeva RN, Nikoda VV, Petrov RO. [Clinical use of ketorolac (ketrodole) for analgesia in the early postoperative period]. Anesteziol Reanimatol. 1995 Jan-Feb;(1):29-31. PMID: 7605030.
* Hubbell K. Problems and pitfalls in providing acute and short-term pain relief with nonsteroidal anti-inflammatory agents. J La State Med Soc. 1996 Jan;148(1):13-8. PMID: 8576628.
* Ma W, Du W, Eisenach JC. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 2002 May 24;937(1-2):94-9. doi: 10.1016/s0006-8993(02)02593-3. PMID: 12020867.
* Cortiñas Sáenz M, Gerónimo Pardo M, Cortiñas Sáenz ML, Hernández Vallecillo MT, Ibarra Martí ML, Mateo Cerdán CM. [Acute opiate tolerance and postoperative hyperalgesia after a brief infusion of remifentanil managed with multimodal analgesia]. Rev Esp Anestesiol Reanim. 2008 Jan;55(1):40-2. doi: 10.1016/s0034-9356(08)70496-1. PMID: 18333385.
* Isiordia-Espinoza MA, Sánchez-Prieto M, Tobías-Azúa F, Reyes-García JG. Pre-emptive analgesic effectiveness of meloxicam versus tramadol after mandibular third molar surgery: a pilot study. J Oral Maxillofac Surg. 2012 Jan;70(1):31-6. doi: 10.1016/j.joms.2011.03.039. Epub 2011 Jul 23. PMID: 21783298.
* Neri E, Maestro A, Minen F, Montico M, Ronfani L, Zanon D, Favret A, Messi G, Barbi E. Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: a double-blind, randomised, controlled trial. Arch Dis Child. 2013 Sep;98(9):721-4. doi: 10.1136/archdischild-2012-303527. Epub 2013 May 23. PMID: 23702435.
* Vygonskaya MV, Filatova EG. [Muscle-skeletal pain]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(1):94-98. doi: 10.17116/jnevro20161161194-98. PMID: 27042717.
* Shi M, Liu R, Fang H, Wu Y, Chen C, Kong B, Zhou Q. Pagoda-Shaped Adhesive Microneedles Loaded with Ketorolac for Aortic Dissection Treatment. ACS Appl Mater Interfaces. 2025 Jun 11;17(23):33412-33421. doi: 10.1021/acsami.5c02565. Epub 2025 May 30. PMID: 40444930.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.